COMMUNIQUÉS West-GlobeNewswire

Balt secures €355 million to refinance its debt and accelerate its growth

20/12/2024 - 16:46

PARIS and MONTMORENCY, France, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Balt, a global medical device leader in interventional neuroradiology, announces that it has secured €355 million in financing from a group of leading [...]

Result of AGM

20/12/2024 - 17:00

DXS INTERNATIONAL PLC (AQSE: DXSP) Result of DXS AGM 2024 The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems [...]

ALK – Financial calendar for the 2025 financial year

20/12/2024 - 17:09

2025 financial calendar for ALK ( ALKB:DC / OMX: ALK B / AKBLF ): 22 January 2025: Silent period 19 February 2025: Annual report 2024 13 March 2025 at 4.00 p.m.: Annual General Meeting to be held at ALK Bøge Allé 1 2970 [...]

Comprehensive Healthcare Leader Joins NAMI Washington Board of Directors

20/12/2024 - 17:15

YAKIMA, Wash., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is pleased to announce that Cassidy Brown, director of marketing and communications, has been appointed to the National Alliance of Mental [...]

Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care

20/12/2024 - 18:00

News Release Exclusive Industry Role : Avextra is the industry partner in a groundbreaking project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression. Pioneering Research [...]

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

20/12/2024 - 11:41

Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 is a 68-week efficacy and safety trial investigating [...]

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

20/12/2024 - 12:16

~ PEDMARQSI ® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children and young people (1 [...]

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

20/12/2024 - 12:50

Acquisition bolsters Eton’s commercial pediatric endocrinology portfolio Product is now available through AnovoRx, a specialty pharmacy dedicated to serving patients with rare and chronic conditions DEER PARK, Ill., Dec [...]

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

20/12/2024 - 13:00

Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a [...]

Verrica Provides Business and Operational Update

20/12/2024 - 13:00

-- Dispensed applicator units in the fourth quarter of 2024 have exceeded the complete prior quarter even with significant cost reductions in sales and operational infrastructure -- Observed significant reduction in [...]

ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility

20/12/2024 - 13:00

Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA’s Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook RAMSEY, N.J. and BOCA [...]

InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904

20/12/2024 - 13:30

JENA, Germany, Dec. 20, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the first patient [...]

Novo Nordisk A/S - share repurchase programme

20/12/2024 - 13:47

Bagsværd, Denmark, 20 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April [...]

Lowell Farms Inc. Appoints Philippe Faraut as Chief Financial Officer

20/12/2024 - 13:50

SALINAS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born cannabis company with advanced production capabilities including extraction, [...]

Aspargo Labs Appoints General Managers in Spain and Germany to Drive International Expansion

20/12/2024 - 14:00

NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmacy and MedTech company focused on reformulating the world’s most meaningful Rx and OTC medications into [...]

Aridis Provides Corporate Update

20/12/2024 - 14:00

LOS GATOS, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, today announced a corporate update on recent developments. Company [...]

Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025

20/12/2024 - 14:00

LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch bio-hybrid organ as a [...]

Altamira Therapeutics Announces Transition from NASDAQ to OTC Markets

20/12/2024 - 14:00

HAMILTON, BERMUDA, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Trading to continue under ticker symbol “CYTOF” No reverse stock split planned Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (OTCQB: CYTOF), a company [...]

Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH

20/12/2024 - 14:00

In the pre-specified per-protocol population, belapectin showed a statistically significant reduction (p-value < 0.05) in development of esophageal varices in 2mg/kg cohort compared to placebo While there was a [...]